Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Terzic

Showing results (1-10 of 150) with videos related to

Pageof 15
Sort By:
Clinical Pharmacology and Therapeutics|August 25, 1999
New frontiers of cardioprotectionA Terzic
Journal of Molecular and Cellular Cardiology|March 27, 1999
Physical association between recombinant cardiac ATP-sensitive K+ channel subunits Kir6.2 and SUR2AE Lorenz, A Terzic
European Journal of Pharmacology|November 3, 1995
Diadenosine-hexaphosphate is an inhibitory ligand of myocardial ATP-sensitive K+ channelsA Jovanović, A Terzic
The Journal of Physiology|April 15, 1996
Actin microfilament disrupters enhance K(ATP) channel opening in patches from guinea-pig cardiomyocytesA Terzic, Y Kurachi
British Journal of Pharmacology|January 1, 1996
Diadenosine tetraphosphate-induced inhibition of ATP-sensitive K+ channels in patches excised from ventricular myocytesA Jovanovic, A Terzic
Clinical Pharmacology and Therapeutics|July 19, 2017
Affairs of the Heart: Innovation in Cardiovascular Research and DevelopmentP Honig, A Terzic
Clinical Pharmacology and Therapeutics|May 21, 2010
Molecular therapeutics from knowledge to deliveryS A Waldman, A Terzic
Clinical Pharmacology and Therapeutics|October 23, 2012
Advancing pharmacometrics and systems pharmacologyS A Waldman, A Terzic
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1991
On the mechanism of the positive inotropic action of the alpha adrenoceptor agonist, phenylephrine, in isolated rat left atriaA Terzic, S M Vogel
Clinical Pharmacology and Therapeutics|January 21, 2016
Bioinnovation Enterprise: An engine driving breakthrough therapiesS A Waldman, A Terzic
Pageof 15

Showing results (1-10 of 150) with videos related to

Sort By:
Pageof 15
Clinical Pharmacology and Therapeutics|August 25, 1999
New frontiers of cardioprotectionA Terzic
Journal of Molecular and Cellular Cardiology|March 27, 1999
Physical association between recombinant cardiac ATP-sensitive K+ channel subunits Kir6.2 and SUR2AE Lorenz, A Terzic
European Journal of Pharmacology|November 3, 1995
Diadenosine-hexaphosphate is an inhibitory ligand of myocardial ATP-sensitive K+ channelsA Jovanović, A Terzic
The Journal of Physiology|April 15, 1996
Actin microfilament disrupters enhance K(ATP) channel opening in patches from guinea-pig cardiomyocytesA Terzic, Y Kurachi
British Journal of Pharmacology|January 1, 1996
Diadenosine tetraphosphate-induced inhibition of ATP-sensitive K+ channels in patches excised from ventricular myocytesA Jovanovic, A Terzic
Clinical Pharmacology and Therapeutics|July 19, 2017
Affairs of the Heart: Innovation in Cardiovascular Research and DevelopmentP Honig, A Terzic
Clinical Pharmacology and Therapeutics|May 21, 2010
Molecular therapeutics from knowledge to deliveryS A Waldman, A Terzic
Clinical Pharmacology and Therapeutics|October 23, 2012
Advancing pharmacometrics and systems pharmacologyS A Waldman, A Terzic
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1991
On the mechanism of the positive inotropic action of the alpha adrenoceptor agonist, phenylephrine, in isolated rat left atriaA Terzic, S M Vogel
Clinical Pharmacology and Therapeutics|January 21, 2016
Bioinnovation Enterprise: An engine driving breakthrough therapiesS A Waldman, A Terzic
Pageof 15